These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27325688)

  • 1. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
    Bennesch MA; Segala G; Wider D; Picard D
    Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1.
    Kim J; Park UH; Moon M; Um SJ; Kim EJ
    FEBS Lett; 2013 Jan; 587(1):17-22. PubMed ID: 23178685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.
    Zhang X; Tanaka K; Yan J; Li J; Peng D; Jiang Y; Yang Z; Barton MC; Wen H; Shi X
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17284-9. PubMed ID: 24101509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA.
    Ombra MN; Di Santi A; Abbondanza C; Migliaccio A; Avvedimento EV; Perillo B
    Biochim Biophys Acta; 2013 May; 1829(5):480-6. PubMed ID: 23507259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.
    Carascossa S; Dudek P; Cenni B; Briand PA; Picard D
    Genes Dev; 2010 Apr; 24(7):708-19. PubMed ID: 20360387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.
    Moore RL; Faller DV
    J Endocrinol; 2013 Mar; 216(3):273-85. PubMed ID: 23169992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms.
    Sun Y; Chung HH; Woo AR; Lin VC
    Biochim Biophys Acta; 2014 Sep; 1843(9):2067-78. PubMed ID: 24742914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
    Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tristetraprolin represses estrogen receptor α transactivation in breast cancer cells.
    Barrios-García T; Tecalco-Cruz A; Gómez-Romero V; Reyes-Carmona S; Meneses-Morales I; León-Del-Río A
    J Biol Chem; 2014 May; 289(22):15554-65. PubMed ID: 24737323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.
    Cui Y; Niu A; Pestell R; Kumar R; Curran EM; Liu Y; Fuqua SA
    Mol Endocrinol; 2006 Sep; 20(9):2020-35. PubMed ID: 16645043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
    Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
    Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
    Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ
    J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α.
    Purcell DJ; Chauhan S; Jimenez-Stinson D; Elliott KR; Tsewang TD; Lee YH; Marples B; Lee DY
    Mol Endocrinol; 2015 Dec; 29(12):1708-19. PubMed ID: 26505218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.